Kathleen W Saunders1, Susan Shortreed1, Stephen Thielke2,3, Judith A Turner2,4,5, Linda LeResche6, Randi Beck7, Michael Von Korff1. 1. Group Health Research Institute. 2. Departments of Psychiatry and Behavioral Sciences. 3. Geriatric Research, Education, and Clinical Center, Puget Sound Veterans Affairs Medical Center. 4. Rehabilitation Medicine. 5. Anesthesiology and Pain Medicine. 6. Oral Medicine, University of Washington. 7. Department of Physical Medicine and Rehabilitation, Group Health, Seattle, WA.
Abstract
OBJECTIVES: Evaluate health plan interventions targeting physician chronic opioid therapy (COT) prescribing. MATERIALS AND METHODS: In 2006, Group Health's (GH) Integrated Group Practice (IGP) initiated diverse interventions targeting COT prescriber norms and practices. In 2010, the IGP implemented a COT guideline, including a mandated online course for physicians managing COT. These interventions were not implemented in GH's network practices. We compared trends in GH-IGP and network practices for 2006 to 2012 in the percent of patients receiving COT and their opioid dose. We compared physician beliefs before versus after the mandated course and precourse to postcourse changes in COT dosing for IGP physicians who took the course. RESULTS: From 2006 to 2012, mean (SE) daily opioid dose among IGP COT patients (intervention setting) declined from 74.1 mg (1.9 mg) morphine equivalent dose (MED) to 48.3 mg (1.0 mg) MED. Dose changes among GH network COT patients (control setting) were modest-88.2 mg (5.0 mg) MED in 2006 to 75.7 mg (2.3 mg) MED in 2012. Among physicians taking the mandated course in 2011, we observed precourse to postcourse changes toward more conservative opioid prescribing beliefs. However, COT dosing trends did not change precourse to postcourse. DISCUSSION: Following initiatives implemented to alter physician prescribing practices and norms, mean opioid dose prescribed to COT patients declined more in intervention than control practices. Physicians reported more conservative beliefs regarding opioid prescribing immediately after completing an online course in 2011, but the course was not associated with additional reductions in mean daily opioid dose prescribed by physicians completing the course.
OBJECTIVES: Evaluate health plan interventions targeting physician chronic opioid therapy (COT) prescribing. MATERIALS AND METHODS: In 2006, Group Health's (GH) Integrated Group Practice (IGP) initiated diverse interventions targeting COT prescriber norms and practices. In 2010, the IGP implemented a COT guideline, including a mandated online course for physicians managing COT. These interventions were not implemented in GH's network practices. We compared trends in GH-IGP and network practices for 2006 to 2012 in the percent of patients receiving COT and their opioid dose. We compared physician beliefs before versus after the mandated course and precourse to postcourse changes in COT dosing for IGP physicians who took the course. RESULTS: From 2006 to 2012, mean (SE) daily opioid dose among IGP COT patients (intervention setting) declined from 74.1 mg (1.9 mg) morphine equivalent dose (MED) to 48.3 mg (1.0 mg) MED. Dose changes among GH network COT patients (control setting) were modest-88.2 mg (5.0 mg) MED in 2006 to 75.7 mg (2.3 mg) MED in 2012. Among physicians taking the mandated course in 2011, we observed precourse to postcourse changes toward more conservative opioid prescribing beliefs. However, COT dosing trends did not change precourse to postcourse. DISCUSSION: Following initiatives implemented to alter physician prescribing practices and norms, mean opioid dose prescribed to COT patients declined more in intervention than control practices. Physicians reported more conservative beliefs regarding opioid prescribing immediately after completing an online course in 2011, but the course was not associated with additional reductions in mean daily opioid dose prescribed by physicians completing the course.
Authors: Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski Journal: J Pain Date: 2009-02 Impact factor: 5.820
Authors: Meldon Kahan; Tara Gomes; David N Juurlink; Michael Manno; Lynn Wilson; Angela Mailis-Gagnon; Anita Srivastava; Rhoda Reardon; Irfan A Dhalla; Muhammad M Mamdani Journal: Can Fam Physician Date: 2013-05 Impact factor: 3.275
Authors: Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner Journal: Clin J Pain Date: 2008 Jul-Aug Impact factor: 3.442
Authors: Brent A Metfessel; Michelle D Mentel; Amy Phanel; Mary Ann Dimartino; Mureen Allen; Samuel Ho Journal: Pharmacoeconomics Date: 2019-03 Impact factor: 4.981
Authors: Jane M Liebschutz; Ziming Xuan; Christopher W Shanahan; Marc LaRochelle; Julia Keosaian; Donna Beers; George Guara; Kristen O'Connor; Daniel P Alford; Victoria Parker; Roger D Weiss; Jeffrey H Samet; Julie Crosson; Phoebe A Cushman; Karen E Lasser Journal: JAMA Intern Med Date: 2017-09-01 Impact factor: 21.873
Authors: Michael Von Korff; Sascha Dublin; Rod L Walker; Michael Parchman; Susan M Shortreed; Ryan N Hansen; Kathleen Saunders Journal: J Pain Date: 2015-10-22 Impact factor: 5.820
Authors: Manu Thakral; Rod L Walker; Kathleen Saunders; Susan M Shortreed; Sascha Dublin; Michael Parchman; Ryan N Hansen; Evette Ludman; Karen J Sherman; Michael Von Korff Journal: Pain Med Date: 2018-12-01 Impact factor: 3.750
Authors: Benjamin J Morasco; Melissa H Adams; Elizabeth R Hooker; Patricia E Maloy; Erin E Krebs; Travis I Lovejoy; Somnath Saha; Steven K Dobscha Journal: J Gen Intern Med Date: 2022-03-16 Impact factor: 5.128
Authors: Daina B Esposito; M Soledad Cepeda; Crystal N Holick; Caitlin Knox; Vibha Ca Desai; Nianya Liu; Shiva-Krishna Vojjala; Jennifer G Lyons; Gregory P Wedin; Stephan Lanes Journal: J Pain Res Date: 2020-01-16 Impact factor: 3.133
Authors: Michiel J Bakkum; Jelle Tichelaar; Anne Wellink; Milan C Richir; Michiel A van Agtmael Journal: Clin Pharmacol Ther Date: 2019-07-29 Impact factor: 6.875